Geode Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-315,377
| Closed | -$473K | – | 4831 |
|
|
2023
Q1 | $473K | Hold |
315,377
| – | – | ﹤0.01% | 3665 |
|
|
2022
Q4 | $314K | Sell |
315,377
-773
| -0.2% | -$770 | ﹤0.01% | 3870 |
|
|
2022
Q3 | $569K | Buy |
316,150
+4,686
| +2% | +$8.43K | ﹤0.01% | 3656 |
|
|
2022
Q2 | $903K | Sell |
311,464
-227,546
| -42% | -$660K | ﹤0.01% | 3475 |
|
|
2022
Q1 | $1.49M | Sell |
539,010
-82,442
| -13% | -$227K | ﹤0.01% | 3416 |
|
|
2021
Q4 | $2.9M | Buy |
621,452
+167,119
| +37% | +$779K | ﹤0.01% | 3188 |
|
|
2021
Q3 | $3.87M | Sell |
454,333
-37,503
| -8% | -$319K | ﹤0.01% | 3058 |
|
|
2021
Q2 | $8.07M | Buy |
491,836
+36,526
| +8% | +$599K | ﹤0.01% | 2615 |
|
|
2021
Q1 | $10.1M | Buy |
455,310
+80,912
| +22% | +$1.79M | ﹤0.01% | 2362 |
|
|
2020
Q4 | $11.6M | Buy |
374,398
+27,205
| +8% | +$841K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $7.05M | Buy |
347,193
+102,685
| +42% | +$2.09M | ﹤0.01% | 2182 |
|
|
2020
Q2 | $3.76M | Buy |
244,508
+53,004
| +28% | +$814K | ﹤0.01% | 2499 |
|
|
2020
Q1 | $1.48M | Buy |
191,504
+15,785
| +9% | +$122K | ﹤0.01% | 2833 |
|
|
2019
Q4 | $2.51M | Buy |
175,719
+13,548
| +8% | +$193K | ﹤0.01% | 2873 |
|
|
2019
Q3 | $2.44M | Buy |
162,171
+121,894
| +303% | +$1.83M | ﹤0.01% | 2815 |
|
|
2019
Q2 | $576K | Buy |
+40,277
| New | +$576K | ﹤0.01% | 3414 |
|